Access the full text.
Sign up today, get DeepDyve free for 14 days.
E. Fenton (2006)
Liberal Eugenics & Human Nature: Against HabermasHastings Center Report, 36
F. Collins (2010)
Has the revolution arrived?Nature, 464
S. Tabrizi, J. Brotherton, J. Kaldor, S. Skinner, Eleanor Cummins, Bette Liu, D. Bateson, K. McNamee, M. Garefalakis, S. Garland (2012)
Fall in human papillomavirus prevalence following a national vaccination program.The Journal of infectious diseases, 206 11
F. Kamm (2006)
What is and is Not Wrong with Enhancement?John F. Kennedy School of Government Faculty Research Working Paper Series
O. Lev (2011)
Will Biomedical Enhancements Undermine Solidarity, Responsibility, Equality and Autonomy?Health Economics eJournal
C. Gartner, J. Barendregt, Angela Wallace, W. Hall (2012)
Would vaccination against nicotine be a cost-effective way to prevent smoking uptake in adolescents?Addiction, 107 4
Sarah Chan, John Harris (2008)
In Support of Human EnhancementStudies in Ethics, Law, and Technology, 1
B. Wilfond, G. Geller, C. Lerman, J. Audrain-McGovern, Alexandra Shields (2002)
Ethical issues in conducting behavioral genetics research: the case of smoking prevention trials among adolescents.Journal of health care law & policy, 6 1
W. Hall, C. Gartner (2011)
Ethical and policy issues in using vaccines to treat and prevent cocaine and nicotine dependenceCurrent Opinion in Psychiatry, 24
J. Colgrove (2006)
The ethics and politics of compulsory HPV vaccination.The New England journal of medicine, 355 23
T. Lewens (2009)
Enhancement and human nature: the case of SandelJournal of Medical Ethics, 35
S. Starr, K. Jameson, Annu Hogquist, Rev, J Roose, M. Mollenauer, V. Gupta, J. Stone, A. Weiss, L Berg, L. Finkelstein, J. Lucas, P. Schwartzberg, M Fukuda, T. Kojima, H. Kabayama, K. Mikoshiba, J. Biol, K Ching, Y. Kawakami, T. Kawakami, C. Tsoukas, A Guse, E. Greiner, F. Emmrich, K. Brand, Alberola-Ila, A. Altman, N. Gascoigne, G. Koretzky, L. Min, K. Mowen, R. Reisfeld, C. Schmedt, T. Frayling, N. Timpson, M. Weedon, E. Zeggini, R. Freathy, C. Lindgren, J. Perry, K. Elliott, H. Lango, N. Rayner, B. Shields, L. Harries, J. Barrett, S. Ebrahim, D. Lawlor, S. Ring, Y. Ben-Shlomo, L. Ferrucci, R. Loos, C. Palmer
References and Notes Supporting Online Material Materials and Methods Som Text Figs. S1 to S7 References a Common Variant in the Fto Gene Is Associated with Body Mass Index and Predisposes to Childhood and Adult Obesity
J. Evans, E. Meslin, T. Marteau, T. Caulfield (2011)
Deflating the Genomic BubbleScience, 331
O. Lev, F. Miller, E. Emanuel (2010)
The Ethics of Research on Enhancement InterventionsKennedy Institute of Ethics Journal, 20
T. Peachacek, R. Kaufmann, R. Caraballo, C. James, A. McClave, S. Dube (2010)
Vital signs: Current cigarette smoking among adults aged >=18 years --- United States, 2009Morbidity and Mortality Weekly Report, 59
C. Bethell, L. Simpson, S. Stumbo, A. Carle, N. Gombojav (2010)
National, state, and local disparities in childhood obesity.Health affairs, 29 3
J. Grunbaum, L. Kann, S. Kinchen, J. Ross, Joseph Hawkins, R. Lowry, W. Harris, Tim Mcmanus, David Chyen, J. Collins (2004)
Youth risk behavior surveillance--United States, 2003.Morbidity and mortality weekly report. Surveillance summaries, 53 2
L. Ross (2010)
360 Degrees of Human Subjects Protections in Community-Engaged ResearchScience Translational Medicine, 2
A. Buchanan (2009)
Moral Status and Human EnhancementPhilosophy & Public Affairs, 37
R. Field, A. Caplan (2008)
A Proposed Ethical Framework for Vaccine Mandates: Competing Values and the Case of HPVKennedy Institute of Ethics Journal, 18
W. Hall (2005)
Will Nicotine Genetics and a Nicotine Vaccine Prevent Cigarette Smoking and Smoking-Related Diseases?PLoS Medicine, 2
J. Kaprio (2009)
Genetic Epidemiology of Smoking Behavior and Nicotine DependenceCOPD: Journal of Chronic Obstructive Pulmonary Disease, 6
Sarah Ramowski, R. Nystrom, N. Chaumeton, K. Rosenberg, J. Gilchrist (2010)
"Choking game" awareness and participation among 8th graders - Oregon, 2008.Morbidity and Mortality Weekly Report, 59
K. Mcmahon-Parkes (2011)
Is Prevention Better than Cure? A Re-evaluation of the Potential Use of Nicotine Conjugate Vaccine in ChildrenPublic Health Ethics, 4
C. Wade, B. Wilfond, C. McBride (2010)
Effects of genetic risk information on children's psychosocial wellbeing: A systematic review of the literatureGenetics in Medicine, 12
T. Cerny, E. Cerny (2005)
Reply to: Hasman A and Holm S. Nicotine conjugate vaccine: is there a right to a smoking future?Journal of Medical Ethics, 31
W. Hall, R. Mathews, K. Morley (2010)
Being More Realistic about the Public Health Impact of Genomic MedicinePLoS Medicine, 7
B. Wilfond, L. Ross (2009)
From genetics to genomics: ethics, policy, and parental decision-making.Journal of pediatric psychology, 34 6
Michael Sandel (2004)
The case against perfection: what's wrong with designer children, bionic athletes, and genetic engineering.Atlantic monthly, 292 3
J. Pierce, W. Choi, E. Gilpin, A. Farkas, R. Merritt (1996)
Validation of susceptibility as a predictor of which adolescents take up smoking in the United States.Health psychology : official journal of the Division of Health Psychology, American Psychological Association, 15 5
J. Balog (2009)
The moral justification for a compulsory human papillomavirus vaccination program.American journal of public health, 99 4
Health behaviors such as tobacco use contribute significantly to poor health. It is widely recognized that efforts to prevent poor health outcomes should begin in early childhood. Biomedical enhancements, such as a nicotine vaccine, are now emerging and have potential to be used for primary prevention of common diseases. In anticipation of such enhancements, it is important that we begin to consider the ethical and policy appropriateness of their use with children. The main ethical concerns raised by enhancing children relate to their impact on childrens well-being and autonomy. These concerns are significant, however they do not appear to apply in the case of the nicotine vaccine; indeed the vaccine could even further these goals for children. Nevertheless, concerns about broadly applying this enhancement may be more challenging. The vaccine may be less cost-effective than alternative public efforts to prevent tobacco use, utilizing it could distract from addressing the foundational causes of smoking and it might not be publically acceptable. Empirical research about these concerns is needed to ascertain their likelihood and impact as well as how they could be minimized. This research could help determine whether behavior-related enhancements hold promise for improving childrens health.
Public Health Ethics – Oxford University Press
Published: Jul 15, 2013
Read and print from thousands of top scholarly journals.
Already have an account? Log in
Bookmark this article. You can see your Bookmarks on your DeepDyve Library.
To save an article, log in first, or sign up for a DeepDyve account if you don’t already have one.
Copy and paste the desired citation format or use the link below to download a file formatted for EndNote
Access the full text.
Sign up today, get DeepDyve free for 14 days.
All DeepDyve websites use cookies to improve your online experience. They were placed on your computer when you launched this website. You can change your cookie settings through your browser.